researchdhr modest even posit pre-announce guidanc slightli expect boost accret target sentiment indic posit view sector perform-r report cash ep consist posit pre-announce quarterli earn would near high-end guidanc rang see report ep penni recently-rais estim partly-stal consensu commun posit pre-announce organ revenu growth stronger expect touch recently-rais estim manag prior target led life scienc diagnost feel-good includ adjust oper margin expans bp strong increment full-year convers regard guidanc headlin cash ep rang includ impact acquisit consist manag tradit practic bake uncomplet deal howev manag provid updat accret estim initi accret target expect boost lower-than-expect financ cost better perform trim modest divestitur net accret expect vs previous assum deal close quarter-end accret would roughli impli total cash ep guidanc rang touch estim consensu oper forecast organ revenu growth in-lin forecast expect et confer call discuss oper tailwind sever winter flu season on-going coronaviru outbreak expect result well-receiv investor suggest modest posit reaction share cash ep consist posit pre-announce led strength life scienc diagnost report cash ep consist compani posit pre-announce quarterli earn would high-end guidanc rang ep penni recently-rais estim partly-stal consensu commun posit pre-announce organ revenu growth stronger expect touch recently-rais estim manag prior target led life scienc diagnost adjust oper margin expand bp y/i bp estim increment margin strong overal oper line recently-rais estim compris upsid life scienc diagnost environment higher corpor expens line item in-lin final free cash flow convers quarter roughli in-lin season averag compani end year free cash flow convers robust issu cash ep guidanc rang exclud contribut updat deal accret target land given tradit practic includ accret uncomplet transact forecast compani initi cash ep guidanc rang bake accret pend acquisit expect close said manag provid guidelin calibr accret impact deal includ impact recently-announc divestitur biopharma portfolio see report better-than-expect perform base accret busi estim addit abl rais financ deal lower-than-expect interest cost rate vs expect add anoth increment accret total biopharma deal expect accret first year assum deal close quarter-end would impli accret guidanc includ would touch estim consensu oper forecast organ revenu growth in-lin forecast final initi cash ep guidanc rang bracket estim consensu benefit impact three extra sell day earn vs estim result compani report capit market estim compani nameexchangetickerratingrisk qualifierpric targetcurrencypricepric date corporationnysedhr ussector performnot jan et capit market llc dean dray capit market llc andrew krill david lu jeffrey reiv senior click conflict interest disclosur relat corpor dean dray disclosur also avail send written request capit market research publish bay street royal bank plaza floor south tower toronto ontario email right reserv materi may publish broadcast rewritten redistribut form pleas click legal restrict term use applic site use site signifi agreement term use
